A carregar...
Publicação
Management of coronary artery disease in patients undergoing transcatheter aortic valve implantation. A clinical consensus statement from the European Association of Percutaneous Cardiovascular Interventions in collaboration with the ESC Working Group on Cardiovascular Surgery
| Nome: | Descrição: | Tamanho: | Formato: | |
|---|---|---|---|---|
| 1.47 MB | Adobe PDF |
Orientador(es)
Resumo(s)
Significant coronary artery disease (CAD) is a frequent finding in patients with severe aortic stenosis undergoing transcatheter aortic valve implantation (TAVI), and the management of these two conditions becomes of particular importance with the extension of the procedure to younger and lower-risk patients. Yet, the preprocedural diagnostic evaluation and the indications for treatment of significant CAD in TAVI candidates remain a matter of debate. In this clinical consensus statement, a group of experts from the European Association of Percutaneous Cardiovascular Interventions (EAPCI) in collaboration with the European Society of Cardiology (ESC) Working Group on Cardiovascular Surgery aims to review the available evidence on the topic and proposes a rationale for the diagnostic evaluation and indications for percutaneous revascularisation of CAD in patients with severe aortic stenosis undergoing transcatheter treatment. Moreover, it also focuses on commissural alignment of transcatheter heart valves and coronary re-access after TAVI and redo-TAVI.
Descrição
© Europa Digital & Publishing 2023. All rights reserved
Palavras-chave
Aortic stenosis Coronary arterydisease TAVI
Contexto Educativo
Citação
EuroIntervention. 2023 May 15;19(1):37-52
Editora
Europa Digital & Publishing